80238-38-6 Usage
Description
(2-acetylhydrazinylidene)(phenyl)acetic acid is a chemical compound with a molecular formula C12H12N2O3. It is composed of a phenyl group attached to an acetic acid molecule through a hydrazino linkage. This molecule has potential pharmaceutical applications due to its structure, which may allow it to interact with biological targets and influence physiological processes. Further research is necessary to fully understand its properties and potential uses.
Uses
Used in Pharmaceutical Industry:
(2-acetylhydrazinylidene)(phenyl)acetic acid is used as a pharmaceutical candidate for its potential to interact with biological targets and impact physiological processes. Its unique structure may allow it to be developed into a drug with therapeutic effects. Further research is needed to explore its potential applications and efficacy in treating various conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 80238-38-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,0,2,3 and 8 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 80238-38:
(7*8)+(6*0)+(5*2)+(4*3)+(3*8)+(2*3)+(1*8)=116
116 % 10 = 6
So 80238-38-6 is a valid CAS Registry Number.
80238-38-6Relevant articles and documents
Preparation of Alkyl Substituted 1,3,4-Oxadiazin-6-ones by the DCC Induced Cyclization of 2-Oxoalkanoic Acid Acylhydrazones
Padwa, Albert,Eisenbarth, Philipp
, p. 61 - 64 (2007/10/02)
A series of 2,5-disubstituted 1,3,4-oxadiazin-6-ones were prepared by treating syn-2-oxoalkanoic acid acylhydrazones with dicyclohexylcarbodiimide.The isomeric anti isomers produced acylureas when treated with DCC.The cycloaddition reaction of 5-methyl-2-phenyl-1,3,4-oxadiazin-6-one with norbornene was studied and found to give a nitrogen deficient 1:1-cycloadduct.The formation of the product can be rationalized in terms of a Diels-Alder cycloaddition followed by nitrogen extrusion and cyclization of the resulting γ-ketoketene intermediate.
